• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Aeterna Zentaris Inc

+ Add to Watchlist

ET81:GR

0.899 EUR 0.0000.00%

As of 07:20:59 ET on 07/14/2014.

Snapshot for Aeterna Zentaris Inc (ET81)

Open: 0.923 Day's Range: 0.862 - 0.923 Volume: 4,200
Previous Close: 0.899 52wk Range: 0.711 - 1.480 1-Yr Rtn: -38.21%

Stock Chart for ET81

No chart data available.
  • ET81:GR 0.899
  • 1D
  • 1M
  • 1Y
0.899
Interactive ET81 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ET81

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.5600
Est. PEG Ratio -
Market Cap (M EUR) 50.86
Shares Outstanding (M) 56.51
30 Day Average Volume 13,850
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ET81

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ET81

AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval.

David A DoddPresident/CEODennis TurpinSenior VP/CFO
Jude DingesSenior VP/Chief Commercial OfcrRichard SachseSenior VP/Chief Scientific Ofcr
More Company Profile & Key Executives for ET81

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil